Search

everythinglearnresearchcommunity

for

Search:↓

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Wound healing is complex and requires more research to enhance treatment methods.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Preservative-free latanoprost effectively lowers eye pressure with fewer side effects.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

FGF-2&D/P nanoparticles can help treat hair loss.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Some systemic treatments work for nail psoriasis but can have serious side effects.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.